Home · TRON Translational Oncology Mainz

nav.hidden, nav ul [x-cloak], nav ul li ul { display: block !important; } This website requires Javascript for some parts to function properly. Your experience may vary.

May 26th, 2026

Insights into TRON – Visit of Scholarship Students

On 21 May 2026, scholarship students from the SBB “Aufstiegsstipendium” visited TRON for an inside look at translational research, exploring our laboratories, learning about key methods and technologies, and discussing the opportunities and challenges shaping the field. The visit offered an inspiring setting for exchange and gave the students a closer understanding of how translational science connects research and clinical application.

May 13th, 2026

Inspiring exchange at CIMT 2026: Advancing cancer immunotherapy together

More than 560 participants from 25 countries gathered in Mainz for the 23rd CIMT Annual Meeting to discuss the latest advances in cancer immunotherapy and to foster new collaborations across academia, clinic, and industry.

April 23rd, 2026

Seminars in Translational Science

We are excited to welcome our guest speaker Mirco Julian Friedrich from the German Cancer Research Center (DKFZ) at TRON on April 28th and to learn more about his latest research during his talk, “Engineering immune resilience to target cancer and aging.”

April 16th, 2026

TFmed 2026: Driving Translational Medicine Through Collaboration

TFmed 2026 brought together leading scientists from academia, clinics, and industry to explore emerging therapeutic strategies and strengthen cross‑cluster collaboration in translational medicine.

March 16th, 2026

Seminars in Translational Science

We are looking forward to meeting our collaborator Dr. Elda Grabocka from Thomas Jefferson University and Jefferson Health at TRON on March 23rd and to hearing about her research findings within her talk “The Dynamic Life of Stress Granules: Linking Cell Cycle, Metabolism, and Pancreatic Cancer”.

March 4th, 2026

Richtfest für neues Forschungsgebäude HI-TRON Mainz gefeiert

Gestern wurde am neuen Gebäude des Helmholtz-Institutes für Translationale Onkologie Mainz (HI-TRON) feierlich die Richtkrone gehisst. Damit sind die Arbeiten am Rohbau beendet und der Innenausbau des neuen Forschungsgebäudes auf dem Areal der Universitätsmedizin Mainz schreitet voran.

We are TRON

TRON is an independent non-profit translational research organization. We pursue new diagnostics and drugs for the treatment of diseases with high medical need. We apply our transdisciplinary competencies in genomics and immunology to develop novel platforms for the identification and validation of ‘omics’-based biomarkers, to modulate immune system components for use in personalized therapies. Collaborating with academia and industry, TRON executes research at the leading edge to support innovative drug design for human health.

Our new research building

Our new research building is currently under construction on the grounds of Mainz University Medical Center according to a concept by Nickl und Partner architects. This envisions a modern, light-flooded building with laboratory and office areas as well as communication zones with up to 10,800 m² of usable space, which will be integrated into the adjacent green areas and the listed Fichte settlement. As a result of intensive coordination with the city of Mainz and all parties involved, construction preparations have been initiated in record time.

Our Research Focus

TRON conducts collaborative research on disease genomics and therapeutic modulation of the immune system. Specializing in cancer immunology and genomics, our research teams develop tailored bioinformatic and novel biostatistical approaches to identify and characterize disease-relevant molecular targets. We design and improve cutting edge technologies for biomarker discovery and biopharmaceutical development, including platforms for immune-based therapies such as RNA vaccines and cellular therapies.